Bausch Health Companies Inc Stock Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.4B 12.79B | Sales 2025 * | 9.67B 13.16B | Capitalization | 2.48B 3.38B |
---|---|---|---|---|---|
Net income 2024 * | 148M 201M | Net income 2025 * | 389M 530M | EV / Sales 2024 * | 2.44 x |
Net Debt 2024 * | 20.44B 27.82B | Net Debt 2025 * | 19.09B 25.99B | EV / Sales 2025 * | 2.23 x |
P/E ratio 2024 * |
20.1
x | P/E ratio 2025 * |
6.43
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.62% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.80% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |